Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Actinium Pharmaceuticals Inc (NYSE MKT LLC:ATNM)

0.9887
Delayed Data
As of Jan 20
 +0.0225 / +2.33%
Today’s Change
0.86
Today|||52-Week Range
2.46
+12.99%
Year-to-Date
No recent news for Actinium Pharmaceuticals Inc.

Today’s Trading

Previous close0.97
Today’s open1.00
Day’s range0.95 - 1.00
Volume95,121
Average volume (3 months)507,858
Market cap$55.1M
Dividend yield--
Data as of 01/20/2017

Growth & Valuation

Earnings growth (last year)+38.89%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book1.98

Competitors

 Today’s
change
Today’s
% change
NBYNovaBay Pharmaceutic...0.000.00%
OHRPOHR Pharmaceutical I...+0.05+3.33%
OVASOvaScience Inc+0.01+0.65%
AMPEAmpio Pharmaceutical...+0.02+2.05%
Data as of 01/20/2017

Financials

Next reporting dateMarch 3, 2017
EPS forecast (this quarter)-$0.13
Annual revenue (last year)$0.00
Annual profit (last year)-$21.0M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, CFO, Secretary &
Director
Kaushik J. Dave
Senior Director-Finance &
Corporate Development
Steve Oloughlin
Corporate headquarters
New York, New York

Forecasts


Search for Jobs